Correlation Between Pfizer and 26442CBH6

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and 26442CBH6 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and 26442CBH6 into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and DUK 355 15 MAR 52, you can compare the effects of market volatilities on Pfizer and 26442CBH6 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of 26442CBH6. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and 26442CBH6.

Diversification Opportunities for Pfizer and 26442CBH6

0.71
  Correlation Coefficient

Poor diversification

The 3 months correlation between Pfizer and 26442CBH6 is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and DUK 355 15 MAR 52 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DUK 355 15 and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with 26442CBH6. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DUK 355 15 has no effect on the direction of Pfizer i.e., Pfizer and 26442CBH6 go up and down completely randomly.

Pair Corralation between Pfizer and 26442CBH6

Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the 26442CBH6. But the stock apears to be less risky and, when comparing its historical volatility, Pfizer Inc is 1.07 times less risky than 26442CBH6. The stock trades about -0.3 of its potential returns per unit of risk. The DUK 355 15 MAR 52 is currently generating about -0.25 of returns per unit of risk over similar time horizon. If you would invest  7,293  in DUK 355 15 MAR 52 on August 27, 2024 and sell it today you would lose (514.00) from holding DUK 355 15 MAR 52 or give up 7.05% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy80.95%
ValuesDaily Returns

Pfizer Inc  vs.  DUK 355 15 MAR 52

 Performance 
       Timeline  
Pfizer Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's technical and fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.
DUK 355 15 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days DUK 355 15 MAR 52 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unfluctuating performance, the Bond's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for DUK 355 15 MAR 52 investors.

Pfizer and 26442CBH6 Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and 26442CBH6

The main advantage of trading using opposite Pfizer and 26442CBH6 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, 26442CBH6 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 26442CBH6 will offset losses from the drop in 26442CBH6's long position.
The idea behind Pfizer Inc and DUK 355 15 MAR 52 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Complementary Tools

Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device